Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes. ccm. 2020;4(6):736-742. Accessed September 18, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/15983